From: Extracellular vesicles through the blood–brain barrier: a review
Author | Cell of origin | Isolation procedure | Size (nm) | Zeta potential | Positive EV markers | Negative EV markers | Concentration | Total protein |
---|---|---|---|---|---|---|---|---|
Morad et al | MDA-MB-231 | Ultracentrifugation at 100000 g for 90 min at 4 °C | 154.1 ± 7.0 and 158.5 ± 6.0 | N.A | CD9, CD63, Alix | GM130 | 1 × 1011 particles/mL | N.A |
Tominaga et al | MDA-MB-231-luc-D3H1 and MDA-MB-231-luc-D3H2LN | Ultracentrifugation at 110,000 g for 70 min at 4 °C | 100 | N.A | CD63, CD9 | Cytochrome C | 1.2 × 109 particles/mL | N.A |
Chen et al | HEK 293 T cells | Ultracentrifugation 120,000 g for 2.5 h at 4 °C | 96.3 ± 5.4 and 80.3 ± 2.0 | N.A | CD63, CD9, CD81 | N/A | 3 × 108 and 6 × 108 particles/mL | N.A |
Matsumoto et al | Human erythrocytes | SEC | 205.22 ± 1.79 | N.A | Alix | CD235a (RBC) | 1.76 × 109 particles/mL | 0.68 ± 0.11 mg/dish |
Kuroda et al | SK-Mel-28 | ExoQuick-TC (polymer based extraction by precipitation) and MagCapture (Affinity method for phosphatidylserine) | 217.0 ± 4.5 | N.A | CD9,CD81,TSG101,Alix,flotillin-1 | calnexin, GRP78 | 9 × 109 particles/mL | N.A |